Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.reuters.com/business/healthcare-pharmaceuticals/bristol-myers-bowel-disease-drug-fails-meet-main-goal-late-stage-study-2024-03-28/
https://recalls-rappels.canada.ca/en/alert-recall/istodax-romidepsin-restricted-access-program
https://www.reuters.com/legal/bristol-myers-wins-dismissal-lawsuit-over-celgene-drugs-2023-03-01/
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-pharma-gets-usfda-nod-to-market-generic-medication/articleshow/97795222.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dr-reddys-laboratories-other-generic-pharma-companies-in-us-face-antitrust-litigation/articleshow/95688576.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://www.fiercepharma.com/pharma/bristol-myers-squibbs-reblozyl-scores-top-line-treat-positive-results-phase-3-trial
https://www.fiercebiotech.com/biotech/celgene-acceleron-alum-backstrom-tapped-be-top-purveyor-scholar-rock
https://www.biopharmadive.com/news/jounce-vopratelimab-fail-ICOS/630823/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761136
https://www.fiercepharma.com/pharma/bristol-myers-loses-bid-toss-64-billion-cvr-lawsuit-tied-celgene-takeover-breyanzi-approval